A National Institutes of Health grant will fund research at the University of Michigan that tests the theory that an IV-delivered antibody treatment can cross the brain’s protective barrier, one of the biggest hurdles in treating Alzheimer’s disease.
Antibody shuttles could deliver noninvasive drugs directly to brain to treat Alzheimer’s
calendar_today
October 22, 2026
domain
university-of-michigan-ann-arbor